This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.

Extract from the above information

It acts on the lower brain stem of the central nervous system, inhibits multi-synaptic reflexes, blocks nerve conduction from abnormally excited muscles, and produces muscle relaxation. It also acts on the higher centers of the cerebral cortex and has a weak sedative effect.

No specific pharmacological effects mentioned

This product is a central muscle relaxant, which has a selective effect on the central nervous system, especially on neurons in the spinal cord. It inhibits the synaptic reflexes related to skeletal muscle spasms, has an anti-convulsion effect caused by strychnine and electrical stimulation, and has detoxification, sedation and anti-inflammatory effects.